SE447204B - Forfarande for att framstella ett intravenost applicerbart serumeggvite-preparat - Google Patents

Forfarande for att framstella ett intravenost applicerbart serumeggvite-preparat

Info

Publication number
SE447204B
SE447204B SE7800443A SE7800443A SE447204B SE 447204 B SE447204 B SE 447204B SE 7800443 A SE7800443 A SE 7800443A SE 7800443 A SE7800443 A SE 7800443A SE 447204 B SE447204 B SE 447204B
Authority
SE
Sweden
Prior art keywords
iii
fractions
preparation
procedure
concentration
Prior art date
Application number
SE7800443A
Other languages
English (en)
Swedish (sv)
Other versions
SE7800443L (sv
Inventor
M Radowitz
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0185977A external-priority patent/AT367297B/de
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of SE7800443L publication Critical patent/SE7800443L/xx
Publication of SE447204B publication Critical patent/SE447204B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7800443A 1977-01-26 1978-01-16 Forfarande for att framstella ett intravenost applicerbart serumeggvite-preparat SE447204B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH93477 1977-01-26
AT0185977A AT367297B (de) 1977-03-17 1977-03-17 Verfahren zur herstellung eines serumeiweiss-pr[parates

Publications (2)

Publication Number Publication Date
SE7800443L SE7800443L (sv) 1978-07-27
SE447204B true SE447204B (sv) 1986-11-03

Family

ID=25597003

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7800443A SE447204B (sv) 1977-01-26 1978-01-16 Forfarande for att framstella ett intravenost applicerbart serumeggvite-preparat

Country Status (23)

Country Link
US (1) US4216205A (fr)
JP (1) JPS5396315A (fr)
AR (1) AR220328A1 (fr)
AU (1) AU522413B2 (fr)
BE (1) BE863278A (fr)
DD (1) DD133632A5 (fr)
DE (1) DE2801123C2 (fr)
DK (1) DK152334C (fr)
EG (1) EG13119A (fr)
ES (1) ES466385A1 (fr)
FI (1) FI63673C (fr)
FR (1) FR2378524A1 (fr)
GB (1) GB1597204A (fr)
HU (1) HU182554B (fr)
IE (1) IE46304B1 (fr)
IL (1) IL53856A (fr)
IN (1) IN147713B (fr)
NL (1) NL7800606A (fr)
PL (1) PL124730B1 (fr)
SE (1) SE447204B (fr)
SU (1) SU786854A3 (fr)
YU (1) YU16578A (fr)
ZA (1) ZA78295B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322275A (en) * 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
FR2492269A2 (fr) * 1980-01-10 1982-04-23 Ionics Appareil d'electrodialyse et procede de fractionnement de melanges de proteines
US4351710A (en) * 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
EP0072843A1 (fr) * 1981-02-18 1983-03-02 University Patents, Inc. Precipitation de proteines
US4452893A (en) * 1981-08-03 1984-06-05 Cutter Laboratories, Inc. Cell growth medium supplement
US4391801A (en) * 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
DE3245591C2 (de) * 1982-12-09 1986-11-06 Schott Glaswerke, 6500 Mainz Verfahren zur fraktionierten Auftrennung von Stoffgemischen mit Membranen
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
CA2066374C (fr) * 1991-04-19 2002-01-29 Paul E. Segall Solutions
CN1055095C (zh) * 1992-12-11 2000-08-02 上海莱士血制品有限公司 白蛋白的纯化方法
KR100267604B1 (ko) 1993-06-04 2000-11-01 이 세갈 폴 혈장 유사 용액
US6300322B1 (en) 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US5945272A (en) 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6627393B2 (en) * 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
US6680305B1 (en) 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6218099B1 (en) 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6441144B1 (en) 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
US6596262B2 (en) * 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6806355B2 (en) * 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
CA2742994A1 (fr) * 2008-11-12 2010-05-20 Baxter International Inc. Purification de la butyrylcholinesterase par adsorption sur membrane
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
CN110054685A (zh) * 2019-04-26 2019-07-26 兰州兰生血液制品有限公司 一种静注人免疫球蛋白（pH4）低温乙醇组分Ⅲ的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1207477A (en) * 1969-04-29 1970-10-07 Ts I Gematologii I Perelivania Plasma proteins solution
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma
JPS5620287B2 (fr) * 1972-06-19 1981-05-13
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3850903A (en) * 1973-06-21 1974-11-26 S Mankarious Plasma volume expander prepared from cohn iv precipitate using block copolymers of ethylene oxide and polyoxypropylene
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen

Also Published As

Publication number Publication date
FR2378524A1 (fr) 1978-08-25
ES466385A1 (es) 1978-10-01
BE863278A (nl) 1978-05-16
US4216205A (en) 1980-08-05
DK35478A (da) 1978-07-27
DK152334C (da) 1988-07-25
FI63673C (fi) 1983-08-10
NL7800606A (nl) 1978-07-28
SU786854A3 (ru) 1980-12-07
IE46304B1 (en) 1983-04-20
EG13119A (en) 1981-03-31
IL53856A (en) 1981-03-31
HU182554B (en) 1984-02-28
DK152334B (da) 1988-02-22
GB1597204A (en) 1981-09-03
IE780088L (en) 1978-07-26
AR220328A1 (es) 1980-10-31
FI780212A (fi) 1978-07-27
AU522413B2 (en) 1982-06-03
ZA78295B (en) 1978-12-27
IN147713B (fr) 1980-06-07
DE2801123A1 (de) 1978-07-27
PL124730B1 (en) 1983-02-28
JPS5396315A (en) 1978-08-23
DD133632A5 (de) 1979-01-17
SE7800443L (sv) 1978-07-27
JPS6241211B2 (fr) 1987-09-02
FI63673B (fi) 1983-04-29
PL204214A1 (pl) 1978-09-25
FR2378524B1 (fr) 1983-02-04
YU16578A (en) 1983-10-31
DE2801123C2 (de) 1986-01-02
AU3260078A (en) 1979-07-26

Similar Documents

Publication Publication Date Title
SE447204B (sv) Forfarande for att framstella ett intravenost applicerbart serumeggvite-preparat
AU621148B2 (en) Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US4322275A (en) Fractionation of protein mixtures
JP3094167B2 (ja) 免疫血清グロブリンの精製方法
US5300433A (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
US4351710A (en) Fractionation of protein mixtures
US7879331B2 (en) Ultra-high yield intravenous immune globulin preparation
JP2000513377A (ja) プリオンのクロマトグラフィー除去方法
AU2006287833B2 (en) An ultra-high yield intravenous immune globulin preparation
JPH0466455B2 (fr)
EP0512883B1 (fr) Procédé de préparation d'un concentré de facteur XI de la coagulation sanguine à haute activité spécifique, approprié à un usage thérapeutique
US4739039A (en) Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product
US8293242B2 (en) Ultra-high yield of alpha-1-anti-trypsin
JPH0381290A (ja) 精製されたアルブミン溶液の製造方法
EP0555135A1 (fr) Procédé de fabrication de fibrinogène de très haute pureté
US4302445A (en) Method for concentrating and purifying antihemophilic factor or factor VIII
James et al. Development of Large‐Scale Fractionation Methods: III. Preparation of a Factor VIII Concentrate of Intermediate‐Purity 1
KR100361894B1 (ko) 치환크로마토그라피방법및정제된헤모글로빈생성물
JPS6242887B2 (fr)
WO1997003092A1 (fr) Procede pour eliminer le polyethyleneglycol d'une solution de proteines ou de peptides
RU2140287C1 (ru) Способ получения альбумина
CA1102694A (fr) Traduction non-disponible
AT367297B (de) Verfahren zur herstellung eines serumeiweiss-pr[parates
CN117946970A (zh) 一种高品质人血清纯化方法
WO2023215722A1 (fr) Procédés de préparation d'un concentré de pool de cohn à partir de plasma sanguin par ultrafiltration

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7800443-9

Effective date: 19891201

Format of ref document f/p: F